Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis. Issue 1 (28th August 2015)

• Record Type: Journal Article
• Authors: Wangsa, Darawalee; Chowdhury, Salim Akhter; Ryott, Michael; Gertz, E. Michael; Elmberger, Göran; Auer, Gert; Åvall Lundqvist, Elisabeth; Küffer, Stefan; Ströbel, Philipp; Schäffer, Alejandro A.; Schwartz, Russell; Munck‐Wikland, Eva; Ried, Thomas; Heselmeyer‐Haddad, Kerstin
• Is Part Of: International journal of cancer. Volume 138:Issue 1(2016:Jan. 01)
• Page Start: 98
• Page End: 109
• Publication Date: 2015-08-28
• Subjects: Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.29691
• Languages: English
• ISSNs: 0020-7136

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Oral tongue squamous cell carcinoma (OTSCC) is associated with poor prognosis. To improve prognostication, we analyzed four gene probes (<italic>TERC, CCND1, EGFR</italic> and <italic>TP53</italic>) and the centromere probe CEP4 as a marker of chromosomal instability, using fluorescence <italic>in situ</italic> hybridization (FISH) in single cells from the tumors of sixty‐five OTSCC patients (Stage I, <italic>n</italic> = 15; Stage II, <italic>n</italic> = 30; Stage III, <italic>n</italic> = 7; Stage IV, <italic>n</italic> = 13). Unsupervised hierarchical clustering of the FISH data distinguished three clusters related to smoking status. Copy number increases of all five markers were found to be correlated to non‐smoking habits, while smokers in this cohort had low‐level copy number gains. Using the phylogenetic modeling software FISHtrees, we constructed models of tumor progression for each patient based on the four gene probes. Then, we derived test statistics on the models that are significant predictors of disease‐free and overall survival, independent of tumor stage and smoking status in multivariate analysis. The patients whose tumors were modeled as progressing by a more diverse distribution of copy number changes across the four genes have poorer prognosis. This is consistent with the view that multiple genetic pathways need to become deregulated in order for cancer to progress.</p> </abstract>